![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | |
A61K 39/395 | |||
A61P 35/00 |
(11) | Number of the document | 2262833 |
(13) | Kind of document | T |
(96) | European patent application number | 09713029.8 |
Date of filing the European patent application | 2009-02-18 | |
(97) | Date of publication of the European application | 2010-12-22 |
(45) | Date of publication and mention of the grant of the patent | 2013-02-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2009/000443 |
Date | 2009-02-18 |
(87) | Number | WO 2009/103969 |
Date | 2009-08-27 |
(30) | Number | Date | Country code |
0802931 | 2008-02-18 | GB |
(72) |
VINSON, Gavin Paul, GB
BARKER, Stewart, GB
PUDDEFOOT, John, Richard, GB
|
(73) |
Queen Mary & Westfield College, University of London,
Mile End Road, London E1 4NS,
GB
|
(54) | SYNTHETIC SCFV ANALOGUE TO THE 6313/G2 (ANTI ANGIOTENSIN II TYPE 1 RECEPTOR) MONOCLONAL ANTIBODY VARIABLE REGIONS |
SYNTHETIC SCFV ANALOGUE TO THE 6313/G2 (ANTI ANGIOTENSIN II TYPE 1 RECEPTOR) MONOCLONAL ANTIBODY VARIABLE REGIONS |